| BORCHMANN, P., A. ENGERT, A. PLUETSCHOW, M. FLUCHS, J. MARKOVA, A. LOHRI, Zdeněk KRÁL, R. GREIL, M. TOPP, M. VILLALOBOS, J. ZIJLSTRA, M. SOEKLER, H. STEIN, H. EICH, R. MUELLER and V. DIEHL. Dose-Intensified Combined Modality Treatment with 2 Cycles of BEACOPP Escalated Followed by 2 Cycles of ABVD and IF-RT in Patients with Early Unfavourable Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Study Group (GHSG) HD14 Trial. Blood. 2008, vol. 112, No 11, p. 143-143. |
Other formats:
BibTeX
LaTeX
RIS
@article{822051,
author = {Borchmann, P. and Engert, A. and Pluetschow, A. and Fluchs, M. and Markova, J. and Lohri, A. and Král, Zdeněk and Greil, R. and Topp, M. and Villalobos, M. and Zijlstra, J. and Soekler, M. and Stein, H. and Eich, H. and Mueller, R. and Diehl, V.},
article_number = {11},
journal = {Blood},
title = {Dose-Intensified Combined Modality Treatment with 2 Cycles of BEACOPP Escalated Followed by 2 Cycles of ABVD and IF-RT in Patients with Early Unfavourable Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Study Group (GHSG) HD14 Trial},
volume = {112},
year = {2008}
}
TY - JOUR
ID - 822051
AU - Borchmann, P. - Engert, A. - Pluetschow, A. - Fluchs, M. - Markova, J. - Lohri, A. - Král, Zdeněk - Greil, R. - Topp, M. - Villalobos, M. - Zijlstra, J. - Soekler, M. - Stein, H. - Eich, H. - Mueller, R. - Diehl, V.
PY - 2008
TI - Dose-Intensified Combined Modality Treatment with 2 Cycles of BEACOPP Escalated Followed by 2 Cycles of ABVD and IF-RT in Patients with Early Unfavourable Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Study Group (GHSG) HD14 Trial
JF - Blood
VL - 112
IS - 11
SP - 143-143
EP - 143-143
ER -
BORCHMANN, P., A. ENGERT, A. PLUETSCHOW, M. FLUCHS, J. MARKOVA, A. LOHRI, Zdeněk KRÁL, R. GREIL, M. TOPP, M. VILLALOBOS, J. ZIJLSTRA, M. SOEKLER, H. STEIN, H. EICH, R. MUELLER and V. DIEHL. Dose-Intensified Combined Modality Treatment with 2 Cycles of BEACOPP Escalated Followed by 2 Cycles of ABVD and IF-RT in Patients with Early Unfavourable Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Study Group (GHSG) HD14 Trial. \textit{Blood}. 2008, vol.~112, No~11, p.~143-143.
|
